According to the Zhitong Finance App, Mace Health (02415.HK) announced its 2026 interim results. The group's revenue for the period was 117 million yuan (RMB, same below), a year-on-year decrease of 6.2%; net profit of 10.638 million yuan, a decrease of 19.7%; and basic profit per share of 1.94 points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.